Loading insider details...
Beta
Latest Form 4 (Apr 2, 2025): Tax Withholding of 7,525 BCRX shares, $56.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 2, 2025 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Tax Withholding | 7,525 | $56.4K |
| Dec 23, 2024 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 125,950 | n/a |
| Dec 17, 2024 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Tax Withholding | 7,150 | $53.8K |
| May 15, 2024 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Purchase | 30,000 | $175.8K |
| Apr 2, 2024 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Tax Withholding | 7,525 | $38.2K |
| Feb 12, 2024 | ImmunoGen, Inc. (IMGN) | Disposition to Issuer | 3,074 | n/a |
| Dec 20, 2023 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Tax Withholding | 5,580 | $33.8K |
| Dec 18, 2023 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 51,000 | n/a |
| Apr 5, 2023 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Sale | 7,000 | $58.0K |
| Dec 21, 2022 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 81,000 | n/a |